ArticleJournal for immunotherapy of cancer2022

Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab.

Roberto Benelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.